検索結果 - Ina Kötter

結果の絞り込み
  1. 1
    Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis

    Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis 著者: Ina Kötter

    出版事項 2003
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  2. 2
    B Cells Contribute to Heterogeneity of IL-17 Producing Cells in Rheumatoid Arthritis and Healthy Controls

    B Cells Contribute to Heterogeneity of IL-17 Producing Cells in Rheumatoid Arthritis and Healthy Controls 著者: Martin Schlegel, Ingeborg Steiert, Ina Kötter, Claudia Müller

    出版事項 2013
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  3. 3
    Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe

    Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe 著者: Philipp Zanger, Ina Kötter, Peter G. Kremsner, Sabine Gabrysch

    出版事項 2011
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  4. 4
    Treatment of ocular symptoms of Behcet's disease with interferon alpha 2a: a pilot study

    Treatment of ocular symptoms of Behcet's disease with interferon alpha 2a: a pilot study 著者: Ina Kötter, A.-K. Eckstein, Nicole Stübiger, Manfred Zierhut

    出版事項 1998
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus

    Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus 著者: Patrice Decker, Ina Kötter, Reinhild Klein, B Berner, Hans‐Georg Rammensee

    出版事項 2006
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    Nucleosome, the Main Autoantigen in Systemic Lupus Erythematosus, Induces Direct Dendritic Cell Activation via a MyD88-Independent Pathway: Consequences on Inflammation

    Nucleosome, the Main Autoantigen in Systemic Lupus Erythematosus, Induces Direct Dendritic Cell Activation via a MyD88-Independent Pathway: Consequences on Inflammation 著者: Patrice Decker, Harpreet Singh‐Jasuja, Sabine Haager, Ina Kötter, Hans‐Georg Rammensee

    出版事項 2005
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis

    Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis 著者: Christoph Deuter, Ina Kötter, İlhan Günaydın, Nicole Stübiger, Deshka Doycheva, Manfred Zierhut

    出版事項 2009
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    Long‐term remission after cessation of interferon‐α treatment in patients with severe uveitis due to Behçet's disease

    Long‐term remission after cessation of interferon‐α treatment in patients with severe uveitis due to Behçet's disease 著者: Christoph Deuter, Manfred Zierhut, Antje Corinna Möhle, Reinhard Vonthein, Nicole Stöbiger, Ina Kötter

    出版事項 2010
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  9. 9
    Daratumumab for autoimmune diseases: a systematic review

    Daratumumab for autoimmune diseases: a systematic review 著者: Marie‐Therese Holzer, Nikolas Ruffer, Tobias B. Huber, Ina Kötter, Lennard Ostendorf, Martin Krusche

    出版事項 2023
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  10. 10
    New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review

    New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review 著者: Marie‐Therese Holzer, Martin Krusche, Nikolas Ruffer, Heinrich Haberstock, Marlene Stephan, Tobias B. Huber, Ina Kötter

    出版事項 2022
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  11. 11
    Evolution of cost structures in rheumatoid arthritis over the past decade

    Evolution of cost structures in rheumatoid arthritis over the past decade 著者: Dörte Huscher, Thomas Mittendorf, U. von Hinüber, Ina Kötter, Guido Hoese, Andrea Pfäfflin, Sascha Bischoff, A. Zink

    出版事項 2014
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  12. 12
    Comparative analysis of large language models and traditional diagnostic decision support systems for rare rheumatic disease identification

    Comparative analysis of large language models and traditional diagnostic decision support systems for rare rheumatic disease identification 著者: Patrick Kremer, Hannes Schiebisch, Fabian Lechner, I. Haase, Lasse Cirkel, Ina Kötter, Sebastian Kühn, Martin Krusche, Johannes Knitza

    出版事項 2025
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  13. 13
    Gender-specific differences in Adamantiades–Behçet’s disease manifestations: an analysis of the German registry and meta-analysis of data from the literature

    Gender-specific differences in Adamantiades–Behçet’s disease manifestations: an analysis of the German registry and meta-analysis of data from the literature 著者: Nikolaos G. Bonitsis, Liêm Binh Luong Nguyen, Michael P. LaValley, Nestor Papoutsis, Andreas Altenburg, Ina Kötter, C. Micheli, Carla Maldini, Alfred Mahr, Christos C. Zouboulis

    出版事項 2014
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  14. 14
    Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature

    Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Tra... 著者: Thomas Daikeler, Ina Kötter, C. Bocelli Tyndall, Jane Apperley, Andishe Attarbaschi, Philippe Guardiola, A. Gratwohl, Esa Jantunen, A Marmont, Ferdinando Porretto, Maurizio Musso, Britta Maurer, N. Rinaldi, Riccardo Saccardi, Alan Tyndall

    出版事項 2006
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  15. 15
    Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases

    Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantat... 著者: Dominique Farge, Myriam Labopin, Alan Tyndall, Αthanasios Fassas, Gianluigi Mancardi, JM van Laar, Jian Ouyang, Tomáš Kozák, John J. Moore, Ina Kötter, Virginie Chesnel, A Marmont, Aloïs Gratwohl, Riccardo Saccardi

    出版事項 2009
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  16. 16
    S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis

    S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis 著者: Jan Henrik Schirmer, Peer Aries, Kirsten de Groot, Bernhard Hellmich, Julia U. Holle, C. Kneitz, Ina Kötter, Peter Lamprecht, Ulf Müller‐Ladner, E. Reinhold‐Keller, Christof Specker, Michael Zänker, Frank Moosig

    出版事項 2017
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  17. 17
    EULAR recommendations for the management of Behcet disease

    EULAR recommendations for the management of Behcet disease 著者: Gülen Hatemi, Alan J. Silman, Dongsik Bang, Bahram Bodaghi, Anne Chamberlain, Ahmet Gül, M.H. Houman, Ina Kötter, Ignazio Olivieri, Carlo Salvarani, Petros P. Sfikakis, Aksel Sıva, Miles Stanford, Nicole Stübiger, Sebahattin Yurdakul, Hasan Yazıcı

    出版事項 2008
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  18. 18
    Epidemiological features of Adamantiades-BehÇet's disease in Germany and in Europe

    Epidemiological features of Adamantiades-BehÇet's disease in Germany and in Europe 著者: Christos C. Zouboulis, Ina Kötter, D Djawari, Wilhelm Kirch, Peter Köhl, Falk Ochsendorf, W Keitel, Rudolf Stadler, Uwe Wollina, Ehrhardt Proksch, Rolf Söhnchen, Helmut Weber, Harald Gollnick, Erhard Hölzle, Klaus Fritz, Thomas Licht, Constantin E. Orfanos

    出版事項 1997
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  19. 19
    Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still’s disease

    Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still’s disease 著者: Cem Gabay, Bruno Fautrel, Jürgen Rech, François Spertini, Eugen Feist, Ina Kötter, É. Hachulla, Jacques Morel, Thierry Schaeverbeke, M. Hamidou, Thierry Martin, Bernhard Hellmich, Peter Lamprecht, Hendrik Schulze‐Koops, Delphine S. Courvoisier, Andrew J. Sleight, Eduardo J. Schiffrin

    出版事項 2018
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  20. 20
    Anti-Ku + myositis: an acquired inflammatory protein-aggregate myopathy

    Anti-Ku + myositis: an acquired inflammatory protein-aggregate myopathy 著者: Marie‐Therese Holzer, Akinori Uruha, Andreas Roos, Andreas Hentschel, Anne Schänzer, Joachim Weis, Kristl G. Claeys, Benedikt Schoser, Federica Montagnese, Hans-Hilmar Goebel, Melanie Huber, Sarah Léonard-Louis, Ina Kötter, Nathalie Streichenberger, Laure Gallay, Olivier Benvéniste, Udo Schneider, Corinna Preuße, Martin Krusche, Werner Stenzel

    出版事項 2024
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: